Mechanism
Oxandrolone is a DHT derivative with an anabolic-to-androgenic ratio of approximately 10:1 (compared to testosterone at 1:1). The modified A-ring structure greatly reduces its affinity for the 5-alpha reductase enzyme, meaning it does not convert further to more potent androgens at the scalp or skin. At female doses (5–10mg/day), it promotes protein synthesis and nitrogen retention, increases IGF-1, and preserves lean mass during a deficit. It does not aromatize, so it adds no estrogen load. The virilization risk exists because women are far more androgen-sensitive than men — androgen receptors in female tissues respond at much lower concentrations.
Signs & Symptoms
- POSITIVE: Increased lean muscle density and vascularity within 2–3 weeks
- POSITIVE: Strength gains without proportional body weight increase
- POSITIVE: Enhanced nitrogen retention and recovery
- WARNING: Clitoral sensitivity increase — early sign, monitor carefully
- WARNING: Increased body hair, especially on arms and lower abdomen
- WARNING: Acne along jawline, chest, or back
- STOP SIGNAL: Any voice change, even subtle hoarseness — permanent if ignored
- STOP SIGNAL: Clitoral enlargement — permanent if use continues
Stages
Prevention
- Start at 5mg/day — not 10mg, not 20mg as some sources recommend
- Maximum 10mg/day — this is a ceiling, not a target
- Maximum 8-week cycle — do not extend based on tolerance
- Monitor daily: voice, clitoral sensitivity, body hair, skin oiliness
- Do not stack with other androgens — Anavar alone is the approach for women
- Cycle break of at least 8–12 weeks between cycles
Management Protocol
- At first virilization sign — stop Anavar immediately, do not attempt to continue at lower dose
- Early signs (clitoral sensitivity, mild acne, slight oiliness) — typically reversible within 4–6 weeks of cessation
- Voice changes — consult ENT immediately; reversal is possible if caught very early
- Irreversible changes (established voice deepening, significant clitoral enlargement) — require specialist consultation
- Post-cycle: natural hormone function returns within 4–6 weeks at female doses without PCT drugs
Risk by Compound
| Compound | Risk Level | Notes |
|---|---|---|
| Anavar 5–10mg/day | Low-Medium | Correct female range. Manageable with monitoring. |
| Anavar above 15mg/day | Very High | Virilization risk escalates sharply. Not female-appropriate. |
| Anavar + Clenbuterol | Medium | Common stack. Manageable but increases overall compound burden. |
| Anavar + any testosterone | Avoid | Testosterone is contraindicated in women seeking performance without TRT indication. |
Women ask me about Anavar more than any other compound. My answer is always the same: 5mg, 6 weeks, no exceptions on dose or duration for a first cycle. I have seen women start at 10mg because they read that men take 50mg and assumed it scales. It does not scale. Female androgen sensitivity is 10–15x higher than male. The 5mg dose is not being cautious — it is being pharmacologically accurate.